Functional Neurological Disorder
Stroke 51:1629-1635, Popkirov, S., et al, 2020
Streamlined Hyeracute Magnetic Resonance Imaging Protocol Identifies Tissue-Type Plasminogen Activator-Eligible Stroke Patients When Clinical Impression is Stroke Mimic
Stroke 47:1012-1017, Goyal, M.S.,et al, 2016
Safety of Intravenous Thrombolysis in Stroke Mimics
Stroke 46:1281-1287, Tsivgoulis, G.,et al, 2015
Negative Diffusion-Weighted Imaging After Intravenous Tissue-Type Plasminogen Activator is Rare and Unlikely to Indicate Averted Infarction
Stroke 44-1629-1634, Freeman, J.,et al, 2013
Established Treatments for Acute Ischaemic Stroke
Lancet 369:319-330, Khaja,A.M. &Grotta,J.C., 2007
Stroke Mimicry: Four Cases Eligible for Tissue Plasminogen Activator
The Neurologist 6:220-223, Kirshner, H.S., 2000